Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
doi: https://doi.org/10.1101/2022.07.26.22278072
Lairun Jin
1School of Public Health, Southeast University, Nanjing, Jiangsu Province, P.R China
Rong Tang
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
Shipo Wu
3Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, P.R China
Xiling Guo
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
Lihua Hou
3Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, P.R China
Xiaoqin Chen
4Donghai County Center for Disease Control and Prevention, Donghai, Jiangsu Province, P.R China
Tao Zhu
5Cansino Biologics Inc., Tianjin, P.R China
Jinbo Gou
5Cansino Biologics Inc., Tianjin, P.R China
Haitao Huang
5Cansino Biologics Inc., Tianjin, P.R China
Jin Zhong
4Donghai County Center for Disease Control and Prevention, Donghai, Jiangsu Province, P.R China
Hongxing Pan
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
Lunbiao Cui
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
Yin chen
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
Xin Xia
6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
Jialu Feng
6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
Xue Wang
5Cansino Biologics Inc., Tianjin, P.R China
Qi Zhao
5Cansino Biologics Inc., Tianjin, P.R China
XiaoYu Xu
7Vazyme Biotech Co., Ltd, Nanjing, Jiangsu Province, P.R China
Zhuopei Li
6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
Xiaoyin Zhang
1School of Public Health, Southeast University, Nanjing, Jiangsu Province, P.R China
Jingxin Li
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
8Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, P.R China
Wei Chen
3Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, P.R China
Fengcai Zhu
1School of Public Health, Southeast University, Nanjing, Jiangsu Province, P.R China
2National Health Commission (NHC) Key laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Jiangsu Province, P.R China
6School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, P.R China
8Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, P.R China
Data Availability
The results supporting the findings in this study are available upon request from the corresponding authors.
Posted July 28, 2022.
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
medRxiv 2022.07.26.22278072; doi: https://doi.org/10.1101/2022.07.26.22278072
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
medRxiv 2022.07.26.22278072; doi: https://doi.org/10.1101/2022.07.26.22278072
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12630)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (411)
- Health Economics (717)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2230)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)